CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health DB Segment Context by Quarter
DB Segment Context — Pharmacy & Consumer Wellness (formerly Retail/LTC) Segment Revenue ($M)
Cvs Health DB Segment Context: $33,816M in Q2 2026, up 0.7% from a year earlier.
Latest, Q2 2026
33,816
Period ended Jun 30, 2026
Change on a year earlier
+0.7%
33,581 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
36
Documents cited below
Where the Q2 2026 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up DB Segment Context
Cite this data
StockData. (2026). Cvs Health DB Segment Context ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/db-seg-pcw-rev
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.